Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
High dose oral tamoxifen and subcutaneous interferon alpha-2a for recurrent glioma.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
High dose oral tamoxifen and subcutaneous interferon alpha-2a for recurrent glioma.
High dose oral tamoxifen and subcutaneous interferon alpha-2a for recurrent glioma. J Neurooncol. 1998 Apr; 37(2):169-76.
View in:
PubMed
subject areas
Administration, Oral
Adult
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Brain Neoplasms
Dose-Response Relationship, Drug
Female
Glioma
Humans
Injections, Subcutaneous
Interferon-alpha
Male
Middle Aged
Neoplasm Recurrence, Local
Recombinant Proteins
Survival Analysis
Tamoxifen
Treatment Outcome
authors with profiles
Frederick George Barker II, M.D.